ReviewPharmaceuticals (Basel, Switzerland)2024

Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights.

Aleksandar Jovalekic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.